ArticleVascular medicine (London, England)2021
Pulmonary Embolism Response Team utilization during the COVID-19 pandemic.
Article in Vascular medicine (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Pooled it
- The effect of COVID-19 pandemic on admission, management and mortality of pulmonary embolism in cancer patients.International journal of cardiology. Cardiovascular risk and prevention · 2026Article
- Multidisciplinary Approach to Pulmonary Embolism and the Role of the Pulmonary Embolism Response Team.Current cardiology reports · 2024Review
- Evolution of Pulmonary Embolism Response Teams in the United States: A Review of the Literature.Journal of clinical medicine · 2024Review
Corrections and comments
- Commented on by
Authors and funding
22 authors.
Funding
Abstract
Coronavirus disease 2019 (COVID-19) may predispose patients to venous thromboembolism (VTE). Limited data are available on the utilization of the Pulmonary Embolism Response Team (PERT) in the setting of the COVID-19 global pandemic. We performed a single-center study to evaluate treatment, mortality, and bleeding outcomes in patients who received PERT consultations in March and April 2020, compared to historical controls from the same period in 2019. Clinical data were abstracted from the electronic medical record. The primary study endpoints were inpatient mortality and GUSTO moderate-to-severe bleeding. The frequency of PERT utilization was nearly threefold higher during March and April 2020 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.